TABLE 2.
Plasma/PRBC | Platelet/PRBC | ||||||
---|---|---|---|---|---|---|---|
CAT+ | Off-target | On-target | p | Off-target | On-target | p | |
(n = 524) | (n = 311) | (n = 213) | (n = 408) | (n = 116) | |||
6-h Plasma/PRBC | 0.72 (0.47–0.96) | 0.50 (0.33–0.67) | 1.00 (0.86–1.04) | <0.001 | 0.67 (0.40–0.90) | 0.87 (0.67–1.00) | <0.001 |
6-h Platelet/PRBC | 0.29 (0.00–0.80) | 0.00 (0.00–0.73) | 0.54 (0.00–0.86) | <0.001 | 0.00 (0.00–0.50) | 1.03 (0.86–1.33) | <0.001 |
6-h Plasma | 6 (3–11) | 4 (2–8) | 8 (6–14) | <0.001 | 5 (3–10) | 8 (4–13) | 0.001 |
6-h Platelet | 6 (0–12) | 0 (0–6) | 6 (0–12) | 0.002 | 0 (0–6) | 12 (6–18) | <0.001 |
6-h PRBC | 8 (5–15) | 8 (5–16) | 8 (5–14) | 0.668 | 8 (5–15) | 8 (6–14) | 0.697 |
24-h Plasma/PRBC | 0.75 (0.50–1.00) | 0.52 (0.33–0.70) | 1.00 (0.86–1.22) | <0.001 | 0.69 (0.44–0.94) | 0.83 (0.67–1.10) | <0.001 |
24-h Platelet/PRBC | 0.40 (0.00–0.75) | 0.23 (0.00–0.73) | 0.55 (0.00–0.86) | <0.001 | 0.00 (0.00–0.55) | 1.00 (0.75–1.24) | <0.001 |
24-h Plasma | 7 (4–14) | 5 (2–11) | 10 (6–16) | 0.504 | 7 (4–14) | 9 (5–16) | 0.013 |
24-h Platelet | 6 (0–12) | 3 (0–12) | 6 (0–12) | <0.001 | 0 (0–11) | 12 (6–18) | <0.001 |
24-h PRBC | 10 (6–18) | 9 (6–19) | 10 (6–16) | <0.001 | 10 (6–19) | 9 (6–16) | 0.851 |
Died in 3 h | 57 (10.9) | 49 (15.8) | 8 (3.8) | <0.001 | 54 (13.2) | 3 (2.6) | 0.002 |
Died in 6 h | 87 (16.6) | 68 (21.9) | 19 (8.9) | <0.001 | 79 (19.4) | 8 (6.9) | 0.002 |
Died in 24 h | 116 (22.1) | 83 (26.7) | 33 (15.5) | 0.003 | 103 (25.2) | 13 (11.2) | 0.002 |
Died in 30 d | 169 (32.3) | 113 (36.3) | 56 (26.3) | 0.020 | 137 (33.6) | 32 (27.6) | 0.269 |
All values are n (%) or median (IQR).
CAT+, patients requiring more than 3 U of PRBCs within any hour during the first 6 hours.
On-target, patients with a 6-hour ratio >0.75 and who spent ≥40% of their time above this threshold.
Off-target, all other patients not meeting on-target criteria.
IQR, interquartile range.